Chenyu Liu

Chenyu Liu

Auto-generated profile, based on publicly available information

Chenyu Liu

State Key Laboratory of Fine Chemicals, School of Chemical Engineering, Dalian University of Technology, Dalian, 116024, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2019 in Biomaterials
Verified
Journal Article
Closed access
CLChunyu Liu
Chunyu Liu
XLXia Liu
Xia Liu
CLChenyu Liu
Chenyu Liu
NWNing Wang
Ning Wang
HCHailiang Chen
Hailiang Chen
WQWeihong Qiao
Weihong Qiao

1 December 2021 in Journal of Colloid and Interface Science
Verified
Journal Article
Closed access
WYWeihe Yao
Weihe Yao
CLChenyu Liu
Chenyu Liu
NWNing Wang
Ning Wang
HZHengjun Zhou
Hengjun Zhou
HCHailiang Chen
Hailiang Chen
WQWeihong Qiao
Weihong Qiao

1 March 2022 in Acta Biomaterialia
Verified
Journal Article
Closed access
CLChenyu Liu
Chenyu Liu
HZHengjun Zhou
Hengjun Zhou
SYSimiao Yu
Simiao Yu
HCHailiang Chen
Hailiang Chen
NWNing Wang
Ning Wang
WQWeihong Qiao
Weihong Qiao

30 June 2021 in Materials Chemistry Frontiers
Verified
Journal Article
Closed access
PDF file
WYWeihe Yao
Weihe Yao
CLChenyu Liu
Chenyu Liu
NWNing Wang
Ning Wang
HZHengjun Zhou
Hengjun Zhou
HCHailiang Chen
Hailiang Chen
WQWeihong Qiao
Weihong Qiao
Targeted multi-responsive drug delivery systems with magnetic resonance imaging (MRI) capacity were anticipated as a promising tool for tumor therapy and diagnosis. Herein, we successfully synthesized anisamide-modified and non-modified UV/GSH-responsive molecules (10,10-NB-S-S-P-AA and 10,10-NB-S-S-P-OMe), and celecoxib-modified and non-modified UV/H2O2-responsive molecules (10,10-NB-OA-P-CE and 10,10-NB-OA-P-OMe). The targeted MRI-tracing UV/GSH/H2O2 triple-responsive hybrid liposomes (GNSOPAC) were fabricated by mixing with contrast agent (12,12-NB-DTPA-Gd), 10,10-NB-S-S-P-AA, and 10,10-NB-OA-P-CE in an optimal ratio of 6 : 1 : 1. GNSOPAC liposomes presented high DEE (>60%), favorable stability, good biocompatibility, and superior MRI performance. By MR imaging and fluorescence distribution in vivo, targeted drug-loaded liposomes (GNSOPACD) exhibited superior targeting activity than non-targeted drug-loaded liposomes (GNSOPMD) in the in vitro and in vivo studies. Compared with doxorubicin hydrochloride (DOX·HCl), the treatment of GNSOPACD + UV achieved a better anticancer effect in the in vitro and in vivo study, which may be related to the combined action of DOX·HCl, the celecoxib moiety and photolysis products. Moreover, GNSOPACD + UV exhibited negligible adverse effects during the in vivo treatment. Hence, anisamide and celecoxib co-modified UV/GSH/H2O2 triple-responsive hybrid liposomes with high MRI performance can act as a potential drug delivery system for tumor theranostics.